Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review

Abstract Fibrin biopolymers, previously referred as “fibrin glue” or “fibrin sealants”, are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically, these biomaterials are produced from human fibrinogen and human or animal thrombin, and the possibility of transmission of infectious diseases by human blood is not ruled out. In the 1990s, to overcome this problem, a new heterologous biomaterial composed of a thrombin-like enzyme purified from Crotalus durissus terrificus venom and a cryoprecipitate rich in fibrinogen extracted from buffaloes Bubalus bubalis blood has been proposed. Therefore, a systematic review of studies on exclusively heterologous fibrin sealants published between 1989 and 2018 was carried out using the following databases: PubMed, SciELO and Google Scholar. The keyword used was “heterologous fibrin sealant”. The search resulted in 35 scientific papers in PubMed, four in SciELO and 674 in Google Scholar. After applying the inclusion/exclusion criteria and complete reading of the articles, 30 studies were selected, which formed the basis of this systematic review. It has been observed that the only completely heterologous sealant is the one produced by CEVAP/UNESP. This heterologous biopolymer is proven effective by several studies published in refereed scientific journals. In addition, clinical trials phase I/II for the treatment of chronic venous ulcers authorized by the Brazilian Health Regulatory Agency (ANVISA) were completed. Preliminary results have indicated a safe and promising effective product. Phase III clinical trials will be proposed and required to validate these preliminary findings.

Saved in:
Bibliographic Details
Main Authors: Buchaim,Daniela Vieira, Cassaro,Claudia Vilalva, Shindo,João Vitor Tadashi Cosin, Coletta,Bruna Botteon Della, Pomini,Karina Torres, Rosso,Marcelie Priscila de Oliveira, Campos,Leila Maria Guissoni, Ferreira Jr,Rui Seabra, Barraviera,Benedito, Buchaim,Rogério Leone
Format: Digital revista
Language:English
Published: Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP) 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992019000100207
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1678-91992019000100207
record_format ojs
spelling oai:scielo:S1678-919920190001002072019-11-07Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic reviewBuchaim,Daniela VieiraCassaro,Claudia VilalvaShindo,João Vitor Tadashi CosinColetta,Bruna Botteon DellaPomini,Karina TorresRosso,Marcelie Priscila de OliveiraCampos,Leila Maria GuissoniFerreira Jr,Rui SeabraBarraviera,BeneditoBuchaim,Rogério Leone Fibrin sealant Snake venom Thrombin-like enzyme Cryoprecipitate coagulum Abstract Fibrin biopolymers, previously referred as “fibrin glue” or “fibrin sealants”, are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically, these biomaterials are produced from human fibrinogen and human or animal thrombin, and the possibility of transmission of infectious diseases by human blood is not ruled out. In the 1990s, to overcome this problem, a new heterologous biomaterial composed of a thrombin-like enzyme purified from Crotalus durissus terrificus venom and a cryoprecipitate rich in fibrinogen extracted from buffaloes Bubalus bubalis blood has been proposed. Therefore, a systematic review of studies on exclusively heterologous fibrin sealants published between 1989 and 2018 was carried out using the following databases: PubMed, SciELO and Google Scholar. The keyword used was “heterologous fibrin sealant”. The search resulted in 35 scientific papers in PubMed, four in SciELO and 674 in Google Scholar. After applying the inclusion/exclusion criteria and complete reading of the articles, 30 studies were selected, which formed the basis of this systematic review. It has been observed that the only completely heterologous sealant is the one produced by CEVAP/UNESP. This heterologous biopolymer is proven effective by several studies published in refereed scientific journals. In addition, clinical trials phase I/II for the treatment of chronic venous ulcers authorized by the Brazilian Health Regulatory Agency (ANVISA) were completed. Preliminary results have indicated a safe and promising effective product. Phase III clinical trials will be proposed and required to validate these preliminary findings.info:eu-repo/semantics/openAccessCentro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP)Journal of Venomous Animals and Toxins including Tropical Diseases v.25 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992019000100207en10.1590/1678-9199-jvatitd-2019-0038
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Buchaim,Daniela Vieira
Cassaro,Claudia Vilalva
Shindo,João Vitor Tadashi Cosin
Coletta,Bruna Botteon Della
Pomini,Karina Torres
Rosso,Marcelie Priscila de Oliveira
Campos,Leila Maria Guissoni
Ferreira Jr,Rui Seabra
Barraviera,Benedito
Buchaim,Rogério Leone
spellingShingle Buchaim,Daniela Vieira
Cassaro,Claudia Vilalva
Shindo,João Vitor Tadashi Cosin
Coletta,Bruna Botteon Della
Pomini,Karina Torres
Rosso,Marcelie Priscila de Oliveira
Campos,Leila Maria Guissoni
Ferreira Jr,Rui Seabra
Barraviera,Benedito
Buchaim,Rogério Leone
Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review
author_facet Buchaim,Daniela Vieira
Cassaro,Claudia Vilalva
Shindo,João Vitor Tadashi Cosin
Coletta,Bruna Botteon Della
Pomini,Karina Torres
Rosso,Marcelie Priscila de Oliveira
Campos,Leila Maria Guissoni
Ferreira Jr,Rui Seabra
Barraviera,Benedito
Buchaim,Rogério Leone
author_sort Buchaim,Daniela Vieira
title Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review
title_short Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review
title_full Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review
title_fullStr Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review
title_full_unstemmed Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review
title_sort unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review
description Abstract Fibrin biopolymers, previously referred as “fibrin glue” or “fibrin sealants”, are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically, these biomaterials are produced from human fibrinogen and human or animal thrombin, and the possibility of transmission of infectious diseases by human blood is not ruled out. In the 1990s, to overcome this problem, a new heterologous biomaterial composed of a thrombin-like enzyme purified from Crotalus durissus terrificus venom and a cryoprecipitate rich in fibrinogen extracted from buffaloes Bubalus bubalis blood has been proposed. Therefore, a systematic review of studies on exclusively heterologous fibrin sealants published between 1989 and 2018 was carried out using the following databases: PubMed, SciELO and Google Scholar. The keyword used was “heterologous fibrin sealant”. The search resulted in 35 scientific papers in PubMed, four in SciELO and 674 in Google Scholar. After applying the inclusion/exclusion criteria and complete reading of the articles, 30 studies were selected, which formed the basis of this systematic review. It has been observed that the only completely heterologous sealant is the one produced by CEVAP/UNESP. This heterologous biopolymer is proven effective by several studies published in refereed scientific journals. In addition, clinical trials phase I/II for the treatment of chronic venous ulcers authorized by the Brazilian Health Regulatory Agency (ANVISA) were completed. Preliminary results have indicated a safe and promising effective product. Phase III clinical trials will be proposed and required to validate these preliminary findings.
publisher Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP)
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992019000100207
work_keys_str_mv AT buchaimdanielavieira uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
AT cassaroclaudiavilalva uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
AT shindojoaovitortadashicosin uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
AT colettabrunabotteondella uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
AT pominikarinatorres uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
AT rossomarcelieprisciladeoliveira uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
AT camposleilamariaguissoni uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
AT ferreirajrruiseabra uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
AT barravierabenedito uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
AT buchaimrogerioleone uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview
_version_ 1756429237132197888